;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Arcus Ventures financial update

    Arcus Ventures, New York, N.Y. Business: Finance Date announced: 2014-08-08 Note: Arcus Ventures raised $10 million in a second close of its Arcus Ventures Fund II L.P. fund, bringing the total raised to $45 million. …

    Published on 8/18/2014
  • arGEN-X financial update

    arGEN-X N.V. (Euronext:ARGX), Rotterdam, the Netherlands Business: Antibodies, Cancer, Autoimmune Date announced: 2014-08-11 Note: arGEN-X raised EUR1.8 million ($2.4 million) through the sale of 208,725 shares at EUR8.…

    Published on 8/18/2014
  • Bio-Techne financial update

    Bio-Techne (NASDAQ:TECH), Minneapolis, Minn. Business: Supply/Service Date announced: 2014-08-11 Note: Bio-Techne said its board declared a cash dividend of $0.31 per share to be paid on Aug. 29 to shareholders of …

    Published on 8/18/2014
  • Dendreon financial update

    Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. Business: Cancer Date announced: 2014-08-11 Note: Dendreon said there is a significant risk that the company will not be able to repay or refinance the $620 million in …

    Published on 8/18/2014
  • Innovus financial update

    Innovus Pharmaceuticals Inc. (OTCBB:INNV), San Diego, Calif. Business: Dermatology, Cancer Date announced: 2014-08-06 Note: Innovus increased to $1.5 million from $1 million an 8% convertible debenture commitment from …

    Published on 8/18/2014
  • Resverlogix financial update

    Resverlogix Corp. (TSX:RVX), Calgary, Alberta Business: Cardiovascular, Neurology, Endocrine/Metabolic Date announced: 2014-08-13 Note: At an Aug. 13 meeting, Resverlogix shareholders approved amending its secured loan …

    Published on 8/18/2014
  • Sirona Biochem financial update

    Sirona Biochem Corp. (TSX-V:SBM; OTCQX:SRBCF), Vancouver, B.C. Business: Endocrine/Metabolic Date announced: 2014-08-12 Note: Sirona secured a C$1.2 million ($1.1 million) loan co-funded from Bpifrance and the French …

    Published on 8/18/2014
  • T2 Biosystems financial update

    T2 Biosystems Inc. (NASDAQ:TTOO), Lexington, Mass. Business: Diagnostic Date announced: 2014-08-12 Note: T2 Biosystems raised $8.6 million through the sale of 780,000 shares at $11 to cover the overallotment from its …

    Published on 8/18/2014
  • ViaCyte financial update

    ViaCyte Inc., San Diego, Calif. Business: Endocrine/Metabolic, Gene/Cell therapy Date announced: 2014-08-08 Note: ViaCyte raised $5.4 million in the second close of a series C-1 round, bringing the total raised to $16.5…

    Published on 8/18/2014
  • Zogenix financial update

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Date announced: 2014-05-19 Note: In May, Zogenix repaid and terminated about $40 million in outstanding debt to HealthCare Royalty Partners.

    Published on 8/18/2014
  • Foamix proposes IPO

    Foamix Ltd., Ness Ziona, Israel Business: Drug delivery Date announced: 2014-08-13 Type: IPO To be raised: Up to $74.8 million Shares: TBD Price: TBD Underwriters: Barclays Capital; Cowen; Oppenheimer; Maxim Group Note:…

    Published on 8/18/2014
  • Forward Pharma proposes IPO

    Forward Pharma A/S, Copenhagen, Denmark Business: Autoimmune Date announced: 2014-08-11 Type: IPO To be raised: Up to $200 million Shares: TBD Price: TBD Underwriter: Leerink Partners Note: The company is seeking to …

    Published on 8/18/2014
  • NeoGenomics proposes follow-on

    NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Genomics, Diagnostic, Supply/Service Date announced: 2014-08-14 Type: Follow-on To be raised: TBD Shares: TBD Price prior: $4.88 Underwriters: William Blair; …

    Published on 8/18/2014
  • ProQR Therapeutics proposes IPO

    ProQR Therapeutics B.V., Leiden, the Netherlands Business: Pulmonary Date announced: 2014-08-14 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: Leerink Partners; Deutsche Bank; JMP …

    Published on 8/18/2014
  • Tokai proposes IPO

    Tokai Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Date announced: 2014-08-11 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: BMO Capital Markets; Stifel, Nicolaus; William …

    Published on 8/18/2014
  • Vitae proposes IPO

    Vitae Pharmaceuticals Inc., Fort Washington, Pa. Business: Cardiovascular, Endocrine/Metabolic, Neurology Date announced: 2014-08-12 Type: IPO To be raised: TBD Shares: TBD Price: Up to $55 million Underwriters: Stifel,…

    Published on 8/18/2014
  • Celladon amends follow-on

    Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Business: Cardiovascular, Endocrine/Metabolic, Neurology Date announced: 2014-08-07 Type: Follow-on To be raised: Up to $63.3 million Shares: 4 million Price prior: $13.23…

    Published on 8/11/2014
  • Otonomy amends IPO

    Otonomy Inc., San Diego, Calif. Business: Other, Drug delivery, Infectious Date announced: 2014-08-01 Type: IPO To be raised: Up to $85.3 million Shares: 5.3 million Price: $14-$16 Underwriters: JPMorgan; BofA Merrill …

    Published on 8/11/2014
  • Arch Biopartners completes private placement of units

    Arch Biopartners Inc. (CNSX:ACH), Toronto, Ontario Business: Inflammation, Renal, Cancer Date completed: 2014-08-05 Type: Private placement of units Raised: C$175,140 ($160,253) Units: 625,000 Price: C$0.28 (unit) …

    Published on 8/11/2014
  • Auris Medical completes IPO

    Auris Medical Holding AG (NASDAQ:EARS), Zug, Switzerland Business: Other Date completed: 2014-08-05 Type: IPO Raised: $56.4 million Shares: 9.4 million Price: $6 Shares after offering: 28.2 million Underwriters: …

    Published on 8/11/2014
  • Cardiome completes debt financing

    Cardiome Pharma Corp. (TSX:COM; NASDAQ:CRME), Vancouver, B.C. Business: Cardiovascular Date completed: 2014-07-18 Type: Debt financing Raised: $12 million Shares outstanding prior: 16.5 million Investor: MidCap …

    Published on 8/11/2014
  • Celladon completes debt financing

    Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Business: Cardiovascular, Endocrine/Metabolic, Neurology Date completed: 2014-07-31 Type: Debt financing Raised: $10 million Investor: Hercules Technology Growth Capital …

    Published on 8/11/2014
  • Destiny Pharma completes venture financing

    Destiny Pharma Ltd., Falmer, U.K. Business: Infectious Date completed: 2014-08-04 Type: Venture financing Raised: L2.8 million ($4.7 million) Investors: Angel CoFund; and other investors Note: The company said it raised…

    Published on 8/11/2014
  • Diurnal completes venture financing

    Diurnal Ltd., Cardiff, U.K. Business: Endocrine/Metabolic Date completed: 2014-08-05 Type: Venture financing Raised: L6 million ($10.1 million) Investors: IP Group; and other investors Note: The company said the full …

    Published on 8/11/2014
  • Enumeral Biomedical completes private placement of units

    Enumeral Biomedical Holdings Inc. (OTCQB:ENUM), Cambridge, Mass. Business: Cancer Date completed: 2014-08-04 Type: Private placement of units Raised: $21.5 million Units: 21.5 million Price: $1 (unit) Shares after …

    Published on 8/11/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993